Association of mutant EGFR concentration in circulating cell-free DNA (cfDNA) by ddPCR with tumor burden and prognosis in NSCLC patients treated with EGFR-TKIs.
第一作者机构：[1]Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China[2]WuXi AppTec, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Zhu Yan-juan,Zhang Hai-bo,Liu Yi-hong,et al.Association of mutant EGFR concentration in circulating cell-free DNA (cfDNA) by ddPCR with tumor burden and prognosis in NSCLC patients treated with EGFR-TKIs.[J].JOURNAL OF CLINICAL ONCOLOGY.2016,34(15):doi:10.1200/JCO.2016.34.15_suppl.e23063.
APA：
Zhu, Yan-juan,Zhang, Hai-bo,Liu, Yi-hong,Zhang, Fu-li,Zhu, Ya-zhen...&Li, Yan.(2016).Association of mutant EGFR concentration in circulating cell-free DNA (cfDNA) by ddPCR with tumor burden and prognosis in NSCLC patients treated with EGFR-TKIs..JOURNAL OF CLINICAL ONCOLOGY,34,(15)
MLA：
Zhu, Yan-juan,et al."Association of mutant EGFR concentration in circulating cell-free DNA (cfDNA) by ddPCR with tumor burden and prognosis in NSCLC patients treated with EGFR-TKIs.".JOURNAL OF CLINICAL ONCOLOGY 34..15(2016)
医学